Projects

Postdoctoral Fellow
Ing. Szilvia Kontár, PhD.

National

Current
  • Use of recombinant enzymes with thioglucosidase activity for the transformation of plant glucosinolates and their analogues into biologically active substances with preventive and suppressive effect on neoplasia development
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • -
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • The effect of combined therapy of cisplatin and isothiocyanates on the multidrug resistance phenotype in human leukemia cells
    Program: Other projects
    Duration: 1. 7. 2024 – 31. 12. 2025
  • Biochip systems for targeted glycan analysis of biomarkers for biomedical and biotechnological applications
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • A new insight at isothiocyanates as substances interfering with the homeostasis of neoplastically transformed cells
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
Finished
  • Defense mechanisms of microbial and animal cells in reducing their sensitivity to plant defensive compounds
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Multidrug resistance of leukemia cells - Phenotype caused by interference of multimodal molecular reasons
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Study of alteration in leukemia cells phenotype after induction of ABCB1 membrane transporter
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • The effect of polyphenols on the functions of signal proteins involved in proteins N-glycosylation in the endoplasmic reticulum of leukemia cells, depending on the expression of P-glycoprotein
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • The application of myrosinase for sulforaphane activation in development of a novel product exhibiting cancer prevention effects
    Program: SRDA
    Duration: 1. 7. 2017 – 30. 6. 2021
Employees